STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Cencora, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cencora, Inc. (COR) Form 144 shows proposed and recent insider sales of common stock by Steven Collis. The filing notifies a brokered proposed sale of 14,579 shares with an aggregate market value of $4,227,618.42 scheduled for 08/19/2025 on the NYSE through Fidelity Brokerage Services. The filing also discloses the acquisition history for the shares to be sold: 2,000 shares from restricted stock vesting on 09/30/2023 (compensation) and 12,579 shares from an option exercise dated 08/19/2025 (cash).

Separately, three insider sales by Steven Collis during the past three months are reported: 14,578 shares on 05/20/2025 for $4,283,599.52, 14,579 shares on 06/24/2025 for $4,266,106.98, and 14,578 shares on 07/22/2025 for $4,265,100.54. The filing includes the seller's representation about lack of undisclosed material information and a signature notice regarding legal penalties for misstatement.

Positive

  • Form 144 filed and detailed: The notice identifies broker, share counts, acquisition dates, and aggregate values, meeting Rule 144 disclosure requirements.
  • Acquisition sources disclosed: The filing specifies that shares arose from restricted stock vesting and an option exercise, clarifying the nature of holdings being sold.

Negative

  • Repeated insider dispositions: Three recent sales totaling 43,735 shares generated approximately $12,814,807.04 in gross proceeds, with an additional proposed sale of 14,579 shares (~$4,227,618.42).
  • No 10b5-1 plan date disclosed: The filing lists dates for plan adoption/instruction fields but provides no plan adoption date, so it does not evidence a pre-arranged trading plan in the notice.

Insights

TL;DR: Multiple, regular insider sales totaling about $12.8M recently, plus a proposed sale of ~14.6k shares (~$4.23M).

The disclosed transactions indicate a sequence of sizeable dispositions by the same insider over several months: three executed sales in May, June and July 2025 each around 14.5k shares generating roughly $4.26M each, totaling approximately $12,814,807.04. The scheduled sale on 08/19/2025 would add another 14,579 shares and about $4.23M in market value. From a financial perspective, these are material amounts in absolute dollar terms and represent recurring liquidity events from one individual. The Form 144 provides clear mechanics (broker, share counts, acquisition dates) but contains no explanation of intent beyond standard representations.

TL;DR: Repeated insider sales are documented and properly disclosed, raising governance questions but not proving impropriety.

The filing meets Rule 144 disclosure mechanics by identifying the broker, share counts, acquisition sources (restricted stock vesting and option exercise), and recent sales. Recurrent sales by the same named individual may prompt investor scrutiny about insider alignment with shareholders, yet the form itself contains no allegation of nondisclosure or breach. The signer makes the required representation about absence of undisclosed material information. Without additional context (e.g., pre-arranged trading plan language or company policy), the disclosure is compliant but notable for frequency and scale.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What insider sales does the COR Form 144 disclose?

The filing reports three insider sales by Steven Collis: 14,578 shares on 05/20/2025 for $4,283,599.52, 14,579 shares on 06/24/2025 for $4,266,106.98, and 14,578 shares on 07/22/2025 for $4,265,100.54.

What proposed sale is being reported for COR?

A proposed sale of 14,579 common shares with an aggregate market value of $4,227,618.42 is scheduled for 08/19/2025 on the NYSE via Fidelity Brokerage Services.

How were the shares being sold acquired according to the filing?

The filing states 2,000 shares were acquired via restricted stock vesting on 09/30/2023 (compensation) and 12,579 shares via an option exercise noted as granted 11/13/2019 with an exercise date of 08/19/2025 (cash).

Does the Form 144 indicate a 10b5-1 trading plan date?

No specific plan adoption or instruction date is provided in the filing; the related fields are present but not populated with a plan date.

Which broker is handling the proposed sale?

The broker listed for the proposed sale is Fidelity Brokerage Services LLC at the Smithfield, RI address shown in the notice.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

71.49B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN